BioBlast Pharma Announces Website Availability of Webcast Related to Key Opinion Leader Meeting in Oculopharyngeal Muscular ...
NEW HAVEN, Conn., Nov. 9, 2015 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd., (Nasdaq:ORPN), a clinical-stage biotechnology company developing meaningful therapies for patients with rare and ultra-rare genetic diseases, announced the availability of a webcast …